Pei-Ching Chang

Pei-Ching Chang

Institute of Microbiology and Immunology,
National Yang-Ming University
No. 155, Sec. 2, Linong St., Beitou District, Taipei City 112, Taiwan (R.O.C.)

Get in Touch

  • Tel: +886-2-2826-7111

Email: pcchang@ym.edu.tw

Specialty

  1. Molecular Biology
  2. Tumor Biology
  3. Biochemistry
  4. Organic chemistry
  5. Molecular Toxicology

Education

1991 - 1995
B.S.,Nutrition and Health Department, Taipei Medical College, Taipei, Taiwan
 
1995 - 1997
M.S., Pharmacology Department, Medical College, National Yang Ming University, Taipei, Taiwan
 
1998 - 2005
Ph.D., Institute of Biochemistry and Molecular Biology, School of Life, Science National Yang Ming University, Taiwan
 

Crossed Appointments

1998 - 2000
Graduate Researcher, Institute of Biochemistry and Molecular Biology, National Yang Ming University, Taiwan
 
2000 - 2005
Graduate Researcher, Institute of Biochemistry and Molecular Biology, National Yang Ming University, Taiwan
 
2006 - 2007
Post doctor, Dental Department of University of Kentucky
 
2008 - 2011
Post doctor, Cancer Center of University of Davis
 
2011 - present
Assistant professor, Institute of Microbiology and Immunology
 

Academic Honors and Awards

Dr. Chien-Tien Hsu’s Award in Fourteenth Symposium on Recent Advances in Cellular and Molecular Biology

Publications

Journal articles(*co-corresponding author)

  1. P.C. Chang*, T.Y. Wang, Y.T. Chang, C.Y. Chu, C.L. Lee, H.W. Hsu, T.A. Zhou, Z. Wu, R.H. Kim, S.J. Desai, S. Liu, H.J. Kung. “Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells.” PLoS One (Feb 2014)
  2. C.Y. Cheng, C.H. Chu, H.W. Hsu, F.R. Hsu, C.Y. Tang, W.C. Wang, H.J. Kung, P.C. Chang. “An improved ChIP-seq peak detection system for simultaneously identifying post-translational modified transcription factors by combinatorial fusion, using SUMOylation as an example.” BMC Genomics (Jan 2014)
  3. P.C. Chang, C.Y. Cheng, M. Campbell, Y.C. Yang, H.W. Hsu, T.Y. Chang, C.H. Chu, Y.W. Lee, C.L. Hung, S.M. Lai, C.G. Tepper, W.P. Hsieh, H.W. Wang, C.Y. Tang, W.C. Wang, H.J. Kung. “The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivation.” BMC Genomics (Nov 2013) *co-corresponding author
  4. M. Campbell, K.Y. Kim, P.C. Chang, S. Huerta, B. Shevchenko, D.H. Wang, C. Izumiya, H.J. Kung, Y. Izumiya. “A Lytic Viral Long Non-coding RNA Modulates the Function of a Latent Protein” J Virol. (Nov 2013)
  5. M. Campbell, P.C. Chang, S. Huerta, C. Izumiya, R. Davis, C.G. Tepper, K.Y. Kim, B. Shevchenko, D.H. Wang, J.U. Jung, P.A. Luciw, H.J. Kung, Y. Izumiya. “Protein Arginine Methyltransferase 1-directed Methylation of Kaposi Sarcoma-associated Herpesvirus Latency-associated Nuclear Antigen” J Biol Chem. (Feb 2012)
  6. P.C. Chang, L.D. Fitzgerald, D.A. Hsia, Y. Izumiya, C.Y. Wu, W.P. Hsieh, S.F. Lin, M. Campbell, K.S. Lam, P.A. Luciw, C.G. Tepper, H.J. Kung “Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor” J Virol. (Apr 2011)
  7. P.C. Chang, Y. Izumiya, C.Y. Wu, L.D. Fitzgerald, M. Campbell, T.J. Ellison, K.S. Lam, P.A. Luciw, H.J. Kung “Kaposi's sarcoma associated herpesvirus (KSHV) encodes a SUMO E3 ligase which is SIM-dependent and SUMO-2/3-specific” J Biol Chem (Feb. 2010)
  8. Z. Wu, P.C. Chang, J.C. Yang, C.Y. Chu, L.Y. Wang, N.T. Chen, A.H. Ma, S.J. Desai, S.H. Lo, C.P. Evans, K.S. Lam, and H.J. Kung “Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors” Genes & Cancer (Jan. 2010)
  9. P.C. Chang, L.D. Fitzgerald, A. Van Geelen, Y. Izumiya, T.J. Ellison, D.H. Wang, D.K. Ann, P.A. Luciw, and H.J. Kung “KRAB domain-associated protein-1 as a latency regulator for Kaposi’s sarcoma-associated herpesvirus and its modulation by the viral protein kinase” Cancer Res (July 2009)
  10. P.C. Chang and M. Li “Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor” J Virol, (Jan. 2008)
  11. Y.L. Lin, P.C. Chang, Y. Wang, and M. Li “Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169” Virus Res, (Feb. 2008)
  12. P.C. Chang, C.W. Chi, G.Y. Chau, F.Y. Li, Y.H. Tsai, J.C. Wu and Y.H.W. Lee “DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus associated hepatocellular carcinoma and is involved in cell growth control” Oncogene, (Mar. 2006)
  13. W.F. Chiou, P.C. Chang, C.I. Chou, C.F. Chen “Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps Sinensis ” Life Sciences, (Feb. 2000)

中心發表之文獻

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19

Pubmed source Author: Tzu-Chuan Ho, Yung-Hsuan Wang, Yi-Ling Chen, Wan-Chi Tsai, Che-Hsin Lee, Ku...

2021-02-17

Honeysuckle aqueous extracts induced let-7a suppress EV71 replication and pathogenesis in vitro and in vivo, and predict-able to inhibit SARS-CoV-2

Pubmed source Author: Ying-Ray Lee , Chia-Ming Chang , Yuan-Chieh Yeh , Chi-Ying F Huang , Feng-M...

2021-02-16

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy

Pubmed source Author: Yeh ML, Kuo HT, Huang CI, Huang CF, Hsieh MY, Liang PC, Lin IH, Hsieh MH, L...

2021-02-10

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals

Pubmed source Author: Lin CP, Liang PC, Huang CI, Yeh ML, Hsu PY, Hsu CT, Wei YJ, Liu TW, Hsieh M...

2021-02-04

Positive fecal immunochemical test strongly predicts adenomas in younger adults with fatty liver and metabolic syndrome

Pubmed source Author: Yeh JH, Lin CW, Wang WL, Lee CT, Wu TC, Hsiao PJ, Tseng CH, Wang JY*(王照元) A...

2021-02-03

Role of the NLRP3 Inflammasome: Insights into Cancer Hallmarks

Pubmed source Author: Lin TY, Tsai MC, Tu W, Yeh HC, Wang SC, Huang SP*(黃書彬), Li CY*(李佳陽) Abstras...

2021-02-03

近期焦點

恭賀本中心執行長榮獲「中華民國癌症醫學會癌症醫學終身成就獎」

恭賀本中心執行長獲中華民國癌症醫學會癌症醫學終身成就獎

2025-05-14

恭賀本中心執行長榮獲「經濟部國家產業創新獎」

恭賀本中心陳立宗執行長獲經濟部國家產業創新獎

2025-05-14

Go to top